Rescinnamine

From Wikipedia, the free encyclopedia
Jump to: navigation, search
Rescinnamine
Rescinnamine.svg
Clinical data
Trade names Moderil, Cinnasil, Anaprel
Routes of
administration
oral
ATC code
Legal status
Legal status
  • In general: ℞ (Prescription only)
Identifiers
Synonyms methyl (1R,15S,17R,18R,19S,20S)-6,18-dimethoxy-17-{[(2E)-3-(3,4,5-trimethoxyphenyl)prop-2-enoyl]oxy}-3,13-diazapentacyclo[11.8.0.02,10.04,9.015,20]henicosa-2(10),4(9),5,7-tetraene-19-carboxylate
CAS Number
PubChem CID
IUPHAR/BPS
DrugBank
ChemSpider
UNII
KEGG
ChEBI
ChEMBL
ECHA InfoCard 100.042.232
Chemical and physical data
Formula C35H42N2O9
Molar mass 634.716 g/mol
3D model (Jmol)
  (verify)

Rescinnamine is an angiotensin-converting enzyme inhibitor used as an antihypertensive drug.

It is an vinca alkaloid obtained from Rauwolfia serpentina[1] and other species of Rauwolfia.[2]

Brand names[edit]

Moderil, Cinnasil, Anaprel

References[edit]

  1. ^ FIFE R, MACLAURIN JC, WRIGHT JH (December 1960). "Rescinnamine in treatment of hypertension in hospital clinic and in general practice". British Medical Journal. 2 (5216): 1848–50. doi:10.1136/bmj.2.5216.1848. PMC 2098607Freely accessible. PMID 13699407. 
  2. ^ Balsevich J, Constabel F, Kurz WG (1982). "Alkaloids of Vinca major cv. Variegata.". Planta Med. 44 (2): 91–3. doi:10.1055/s-2007-971409. PMID 17402086.